ClinicalTrials.gg
Active, not recruitingNCT07580391Updated Nov 9, 2026

Utilization of a Web-Based Application to Improve Patient Health Literacy and Reduce Clinic Visit Times in Holmium Laser Enucleation of the Prostate (HoLEP) Procedures and Kidney Stone Surgery

An interventional study of WellPrept and Standard Care in Kidney Stone and Benign Prostatic Hyperplasia, sponsored by Northwestern University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Northwestern University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Sep 2025, registered Apr 2026).
Updated Nov 9, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Non-randomized
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 193 studies in Kidney Calculi with a site in United States — 42 open to participants now, 58 under way, none of them phase 3. Kidney Calculi · United States.

Planned enrollment
9th of 165
300 · median 47
Started
2025
with 18 others
No phase
113 of 193
29 open now
Primary completion
2026-10
later than 18 of 57 live
Registered
189th of 193
by date
Lead sponsor
9 of 193
Northwestern University

Among the 193 studies in Kidney Calculi with a site in United States, this one is the 9th largest by planned enrollment of the 165 interventional ones that give a count, is one of 19 that started in 2025, is one of 113 with no phase, reaches primary completion later than 18 of the 57 other live ones, and was the 189th registered.

Kidney Calculi

510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.

Browse Kidney Calculi studies →

Open to participants now

42 of the 193 studies in Kidney Calculi with a site in United States are open now. Recruiting first, the newest first:

37 more — sign in →

All 42 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 88 Kidney Calculi studies recruiting now, 48 (55%) set no upper age limit and 23 (26%) stop at 75 or younger; 6 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 193 studies in Kidney Calculi with a site in United States, or all of them as a file.
02

Study summary

The investigator and research team plan to investigate whether patients who receive access to WellPrept website will report greater confidence and understanding of their medical condition, have shorter clinic visit times, and fewer post-operative trips to the emergency room.

03

Conditions studied

  • Kidney Stone
  • Benign Prostatic Hyperplasia

Keywords

  • HoLEP
  • kidney stones
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • In the HoLEP arm, men aged 18-100 who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms, that are typically caused by enlarged prostates.
  • In the Kidney stone arm, men and women aged 18-100 who are undergoing surgery for the treatment of stones in the kidney, urinary tract, or bladder.

Exclusion criteria

Exclusion Criteria:

  • Patients with prostates measurements over 200g
  • Patients who lack decisional capacity
  • Patients who are non-English speakers
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Placebo comparator
    Pre-WellPrept

    (Standard Care) Participants enrolled in this arm will not receive access to the WellPrept website containing information about the condition and treatments offered before their consultation regarding BPH/HoLEP and/or kidney stones.

    Other: Standard Care

  • Active comparator
    Post-WellPrept

    (Standard care + WellPrept website) Participants enrolled in this arm will receive access to the WellPrept website containing information about the condition and treatments offered before their consultation regarding BPH/HoLEP and/or kidney stones.

    Other: WellPrept · Other: Standard Care

Interventions

  • OtherWellPrept

    WellPrept is a web-based application created by urologist David Canes to streamline doctor-patient interactions by allowing patients to arrive to their visits well prepared. The idea behind WellPrept is that by providing clear health information ahead of time to patients, that overall patient health literacy will increase, and doctor-patient interactions can be streamlined.

  • OtherStandard Care

    Office based pathway without introducing the WellPrept website to patients

06

What researchers measure

Primary outcomes

  1. Pre-operative and post-operative literacy of either HoLEP for BPH or kidney stones.

    Comparing pre-operative and post-operative literacy of either HoLEP for BPH, after WellPrept. This will be conducted through a questionnaire sent to patients before and after their procedure as well as to the clinician who will be conducting patient follow-ups in order to gauge reported patient understanding from the clinical team and from the patient.

    Time frame: 1 year

Secondary outcomes

  1. Time spent in healthcare encounters

    Comparing time spent (minutes) in healthcare encounters, specifically during clinic visits, pre-operative and post-operative visits, and number of visits to the emergency room after their procedure. This will be determined by timing clinic visits and using the medical record to assess visits to the emergency room.

    Time frame: 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Oct 2026, 13 months.

Of 183 non-industry interventional studies with no phase under Kidney Calculi, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's 13 months is below that.

Counting every sponsor, half of 199 studies reached it within 26 months; a quarter within 12 and three quarters within 51.

Primary completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Nov 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 26, 2026
First posted
May 12, 2026
StartActual
Sep 17, 2025
Primary completionActual
Oct 31, 2026was Sep 2026
CompletionEst.
Sep 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 2026→Oct 31, 2026 (actual)
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Primary completion Sep 2026→Oct 31, 2026 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07580391
Responsible party
Amy Krambeck (Director of the Endourology/Stone Division, Northwestern University) — Principal investigator
First posted
May 12, 2026
Start date
Sep 17, 2025
Primary completion
Oct 31, 2026
Completion
Sep 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Amy E Krambeck, MD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion